Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
02/06

DJ Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bio-Techne Corp. $(TECH)$ slid 4.09% to $65.86 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.23% to 6,798.40 and Dow Jones Industrial Average falling 1.20% to 48,908.72.

Bio-Techne Corp. closed 14.50% below its 52-week high of $77.03, which the company reached on February 6th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 0.44% to $367.80, Charles River Laboratories International Inc. $(CRL)$ fell 8.89% to $183.70, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.82% to $57.15.

Trading volume (2.7 M) eclipsed its 50-day average volume of 2.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 5, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 05, 2026 17:18 ET (22:18 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10